What do Cochrane systematic reviews say about interventions for treating psoriasis?
Keywords:
Review [publication type], Psoriasis, Evidence-based medicine, Evidence-based practiceAbstract
CONTEXT AND OBJECTIVE: Psoriasis is a common chronic inflammatory skin disease characterized by abnormal and increased growth of the cells that produce keratin and abnormal functioning of the immune system. We aimed to summarize the evidence available regarding interventions for patients with psoriasis. DESIGN AND SETTING: Review of systematic reviews, developed in the Discipline of Evidence-Based Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo. METHODS: A systematic search was conducted to identify Cochrane systematic reviews that fulfilled the eligibility criteria. Two authors screened titles and abstracts that had been retrieved through the search strategy. The results from all the Cochrane systematic reviews that were included were summarized and presented in a narrative synthesis. RESULTS: We included six Cochrane systematic reviews assessing interventions for treating psoriasis. The findings from high-quality evidence were that (a) etanercept reduced the psoriasis severity index, compared with placebo and (b) steroids plus vitamin D, compared with vitamin D alone, improved the skin clearance rate, as assessed by investigators, but was associated with a higher proportion of participants who dropped out due to adverse events. For all other comparisons, the quality of the evidence ranged from moderate to very low. CONCLUSION: This review included six Cochrane systematic reviews that provided evidence ranging in quality from unknown to high, regarding management of psoriasis. Further randomized controlled trials are imperative to reduce the uncertainties relating to several treatments that are already used in clinical practice.
Downloads
References
Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-85. PMID: 23014338; doi: 10.1038/jid.2012.339.
Fairhurst DA, Ashcroft DM, Griffiths CEM. Optimal management of severe plaque form of psoriasis. Am J Clin Dermatol. 2005;6(5):283-94. PMID: 16252928; doi: 10.2165/00128071-200506050-00002.
da Silva CAP, Von Kossel K, Leszczynski M, Melnik T, Riera R. Methotrexate for psoriasis (Protocol). Cochrane Database of Syst Rev. 2013;4: CD010498. doi: 10.1002/14651858.CD010498.
Tagami H. Triggering factors. Clin Dermatol. 1997;15(5):677-85. PMID: 9313966; doi: 10.1016/S0738-081X(97)00024-2.
Carretero G, Puig L, Dehesa L, et al. Metotrexato: Guia de uso en psoriasis [Guidelines on the use of methotrexate in psoriasis]. Actas Dermosifiliogr. 2010;101(7):600-13. PMID: 20858386; doi: 10.1016/j.ad.2010.04.002.
Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451-85. PMID: 19493586; doi: 10.1016/j.jaad.2009.03.027.
Oliveira Mde F, Rocha Bde O, Duarte GV. Psoríase: comorbidades clássicas e emergentes [Psoriasis: classical and emerging comorbidities]. An Bras Dermatol. 2015;90(1):9-20. PMID: 25672294; doi: 10.1590/abd1806-4841.20153038.
Mason AR, Mason J, Cork M, Dooley G, Hancock H. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 2013;(3):CD005028. PMID: 23543539; doi: 10.1002/14651858.CD005028.pub3.
Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J Am Acad Dermatol. 2014;70(1):146-67. PMID: 24126079; doi: 10.1016/j.jaad.2013.08.042.
Chi CC, Ko SH, Yeh ML, Wang SH, Tsai YS, Hsu MY. Lifestyle changes for treating psoriasis (Protocol). Cochrane Database Syst Rev. 2015;11: CD011972. doi: 10.1002/14651858.CD011972.
Chi CC. Evidence-based dermatology. Dermatologica Sinica. 2013;31(1):2-6. doi: 10.1016/j.dsi.2012.06.002.
Sanclemente G, Murphy R, Contreras J, García H, Bonfill Cosp X. Anti-TNF agents for paediatric psoriasis. Cochrane Database Syst Rev. 2015;(11): CD010017. PMID: 26598969; doi: 10.1002/14651858.CD010017.pub2.
de Vries AC, Bogaards NA, Hooft L, et al. Interventions for nail psoriasis. Cochrane Database Syst Rev. 2013;(1): CD007633. PMID: 23440816; doi: 10.1002/14651858.CD007633.pub2.
Chen X, Yang M, Cheng Y, Liu GJ, Zhang M. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. Cochrane Database Syst Rev. 2013;(10): CD009481. PMID: 24151011; doi: 10.1002/14651858.CD009481.pub2.
Atwan A, Ingram JR, Abbott R, et al. Oral fumaric acid esters for psoriasis. Cochrane Database Syst Rev. 2015 Aug 10;(8):CD010497. PMID: 26258748; doi: 10.1002/14651858.CD010497.pub2.
Mason AR, Mason J, Cork M, Dooley G, Hancock H. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 2013;(3):CD005828. PMID: 23543539; doi: 10.1002/14651858.CD005028.pub3.
Schlager JG, Rosumeck S, Werner RN, et al. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev. 2016;2:CD009687. PMID: 26915340; doi: 10.1002/14651858.CD009687.pub2.
Maruani A, Samimi M, Stembridge N, et al. Interventions for guttate psoriasis (Protocol). Cochrane Database Syst Rev. 2015;2:CD011541. doi: 10.1002/14651858.CD011541.
Dupire G, Droitcourt C, Ferneiny M, et al. Antistreptococcal interventions for guttate and chronic plaque psoriasis (Protocol). Cochrane Database Syst Rev. 2015;3:CD011571. doi: 10.1002/14651858.CD011571.
Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. PMID: 15205295; doi: 10.1136/bmj.328.7454.1490.
da Silva CAP, Von Kossel K, Leszczynski M, Melnik T, Riera R. Methotrexate for psoriasis (Protocol). Cochrane Database Syst Rev. 2013;4: CD010498. doi: 10.1002/14651858.CD010498.
Peinemann F, Harari M, Peternel S, Chan T, Gambichler T. Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis (Protocol). Cochrane Database Syst Rev. 2015;11: CD011941. doi: 10.1002/14651858.CD011941.
Chi CC, Ko SH, Yeh ML, et al. Lifestyle changes for treating psoriasis (Protocol). Cochrane Database Syst Rev. 2015;11:CD011972. doi: 10.1002/14651858.CD011972.
Monson CA, Silva V, Andriolo RB, et al. Complementary therapies for chronic plaque psoriasis (Protocol). Cochrane Database Syst Rev. 2014;7:CD011243. doi: 10.1002/14651858.CD011243.
Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. PMID: 20332509; doi: 10.1136/bmj.c332.
